Wong, Kai On
Klarenbach, Scott W.
Martins, Karen J. B.
Chue, Pierre
Dursun, Serdar M.
Snaterse, Mark
Guigue, Alexis
So, Helen
Luu, Huong
Vu, Khanh
Richer, Lawrence
Funding for this research was provided by:
Johnson and Johnson Alberta Health Innovation Partnership
Article History
Received: 12 January 2022
Accepted: 17 June 2022
First Online: 2 July 2022
Declarations
:
: Ethics approval (Pro00086993) was obtained from the institutional review board at the University of Alberta. This is a study of administrative data without any intervention. No study participants were placed at risk as a result of this study, and informed consent was not required.
: Not applicable.
: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: SD, HS, and MS have no competing interests to declare. SK, KW, KM, AG, HL, KV, and LR are members of the Real World Evidence Unit, an academic entity at the University of Alberta that conducts research including investigator-initiated industry-funded studies. PC has acted as a consultant and received honoraria and research travel grants from Alkermes, Allergan, Boehringer Ingelheim, HLS Therapeutics, Janssen, Lundbeck, Otsuka, and Sunovion between 2015 and 2021. No other conflict of interest is declared. All authors of this study had complete autonomy over the content and submission of the manuscript, as well as the design and execution of the study.